WORLD JOURNAL OF SURGICAL ONCOLOGY, cilt.9, 2011 (SCI-Expanded, Scopus)
Background: The aim of this study was to evaluate the success of selective intraarterial radionuclide therapy (SIRT) with Yttrium-90 (Y-90) microspheres in liver metastases of different tumors. We also interpreted the contribution of SIRT to survival times according to responder-non responder and hepatic-extra hepatic disease.